# Optiflow vs. Convential Anesthesia During Pediatric Laryngeal Papilloma Removal

> **NCT05215249** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Massachusetts Eye and Ear Infirmary**

## Conditions studied

- Laryngeal Papilloma, Recurrent

## Interventions

- **PROCEDURE:** Transnasal humidified high-flow oxygen delivery

## Key facts

- **NCT ID:** NCT05215249
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IRB approval not received
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05215249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05215249, "Optiflow vs. Convential Anesthesia During Pediatric Laryngeal Papilloma Removal". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05215249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*